The store will not work correctly when cookies are disabled.
(E)-4-(3,4-Dimethoxystyryl)-6-(methylthio)pyrimidin-2-amine
ID: ALA2419785
PubChem CID: 72163453
Max Phase: Preclinical
Molecular Formula: C15H17N3O2S
Molecular Weight: 303.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(/C=C/c2cc(SC)nc(N)n2)cc1OC
Standard InChI: InChI=1S/C15H17N3O2S/c1-19-12-7-5-10(8-13(12)20-2)4-6-11-9-14(21-3)18-15(16)17-11/h4-9H,1-3H3,(H2,16,17,18)/b6-4+
Standard InChI Key: SLCNUVNJEYKIGE-GQCTYLIASA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
12.6523 -3.3748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6511 -4.2022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3659 -4.6150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0823 -4.2017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0794 -3.3712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3641 -2.9621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7924 -2.9561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5083 -3.3658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2212 -2.9506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9356 -3.3638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6480 -2.9494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6454 -2.1235 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.9244 -1.7140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2149 -2.1308 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.9183 -0.8890 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.3638 -3.3595 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
19.0769 -2.9447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3657 -5.4400 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.6512 -5.8523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9363 -4.6141 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.2222 -4.2010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
13 15 1 0
11 16 1 0
16 17 1 0
3 18 1 0
18 19 1 0
2 20 1 0
20 21 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 303.39 | Molecular Weight (Monoisotopic): 303.1041 | AlogP: 2.97 | #Rotatable Bonds: 5 |
Polar Surface Area: 70.26 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.21 | CX LogP: 3.38 | CX LogD: 3.38 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.68 | Np Likeness Score: -0.48 |
References
1. Suryawanshi SN, Kumar S, Shivahare R, Pandey S, Tiwari A, Gupta S.. (2013) Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents., 23 (18): [PMID:23910597] [10.1016/j.bmcl.2013.06.060] |